Shuofeng Yuan

26.1k total citations · 5 hit papers
111 papers, 6.7k citations indexed

About

Shuofeng Yuan is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Shuofeng Yuan has authored 111 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Infectious Diseases, 36 papers in Epidemiology and 34 papers in Molecular Biology. Recurrent topics in Shuofeng Yuan's work include SARS-CoV-2 and COVID-19 Research (37 papers), Influenza Virus Research Studies (23 papers) and COVID-19 Clinical Research Studies (23 papers). Shuofeng Yuan is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (37 papers), Influenza Virus Research Studies (23 papers) and COVID-19 Clinical Research Studies (23 papers). Shuofeng Yuan collaborates with scholars based in Hong Kong, China and United States. Shuofeng Yuan's co-authors include Kwok‐Yung Yuen, Hin Chu, Jasper Fuk‐Woo Chan, Kelvin Kai‐Wang To, Kin‐Hang Kok, Zheng Zhu, Zi‐Wei Ye, Dong‐Yan Jin, Kit‐San Yuen and Chi‐Ping Chan and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Shuofeng Yuan

108 papers receiving 6.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

2020 2.1k citations Jasper Fuk‐Woo Chan, Kin‐Hang Kok et al. Emerging Microbes & Infections profile →
Zoonotic origins of human coronaviruses

2020 600 citations Zi‐Wei Ye, Shuofeng Yuan et al. International Journal of Biological Sciences profile →
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing

2020 449 citations Kelvin Kai‐Wang To, Ivan Fan‐Ngai Hung et al. Clinical Infectious Diseases profile →
Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19)

2020 400 citations Jasper Fuk‐Woo Chan, Shuofeng Yuan et al. Clinical Infectious Diseases profile →
Severe acute respiratory syndrome Coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3‐dependent ubiquitination of ASC

2019 374 citations Kam‐Leung Siu, Kit‐San Yuen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shuofeng Yuan Hong Kong	33	4.4k	1.4k	982	797	709	111	6.7k
Igor A. Sidorov Netherlands	24	4.4k 1.0×	1.2k 0.9×	610 0.6×	738 0.9×	858 1.2×	69	7.1k
Hin Chu Hong Kong	41	6.3k 1.4×	1.8k 1.3×	1.4k 1.4×	1.2k 1.5×	1.3k 1.9×	126	9.2k
Ben Hu China	18	5.6k 1.3×	955 0.7×	581 0.6×	913 1.1×	466 0.7×	34	7.5k
Timothy P. Sheahan United States	37	5.9k 1.3×	1.4k 1.0×	1.1k 1.2×	1.2k 1.5×	925 1.3×	84	8.0k
Benjamin W. Neuman United States	32	6.2k 1.4×	2.0k 1.4×	659 0.7×	874 1.1×	823 1.2×	70	9.1k
Anthony R. Fehr United States	27	4.5k 1.0×	1.5k 1.1×	738 0.8×	927 1.2×	1.1k 1.6×	52	6.8k
Jian‐Piao Cai China	40	4.3k 1.0×	762 0.5×	1.1k 1.1×	687 0.9×	602 0.8×	148	5.7k
Lisa E. Gralinski United States	30	4.1k 0.9×	1.2k 0.9×	627 0.6×	809 1.0×	981 1.4×	53	5.9k
Vineet D. Menachery United States	41	6.2k 1.4×	1.6k 1.1×	748 0.8×	757 0.9×	1.3k 1.8×	86	7.9k
Ravindra K. Gupta United Kingdom	36	5.0k 1.1×	1.5k 1.1×	1.7k 1.7×	353 0.4×	759 1.1×	171	8.0k

Countries citing papers authored by Shuofeng Yuan

Since Specialization

Citations

This map shows the geographic impact of Shuofeng Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuofeng Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuofeng Yuan more than expected).

Fields of papers citing papers by Shuofeng Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuofeng Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuofeng Yuan. The network helps show where Shuofeng Yuan may publish in the future.

Co-authorship network of co-authors of Shuofeng Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Shuofeng Yuan. A scholar is included among the top collaborators of Shuofeng Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuofeng Yuan. Shuofeng Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Na, Yanxia Chen, Can Li, et al.. (2025). Reverse genetics-derived cattle H5N1 virus from Clade 2.3.4.4b shows enhanced systemic infectivity and pathogenicity than an older Clade 1 H5N1 virus in BALB/c mice. Emerging Microbes & Infections. 14(1). 2475836–2475836. 2 indexed citations

Yuan, Shuofeng, et al.. (2025). Discovery of a Small Molecule TREM2 Agonist with Improved In Vitro Pharmacokinetic Profile and Validated Target Engagement. ACS Medicinal Chemistry Letters. 16(8). 1634–1640. 1 indexed citations

Yuan, Shuofeng, et al.. (2025). Discovery of a first-in-class SLIT2 binder disrupting the SLIT2/ROBO1 axis via DNA-encoded library (DEL) screening. RSC Medicinal Chemistry. 16(12). 6059–6067.

Liu, Qian, et al.. (2025). SARS‐CoV‐2 Membrane Protein Induces MARCHF1/GPX4‐Mediated Ferroptosis by Promoting Lipid Accumulation. Journal of Medical Virology. 97(4). e70328–e70328. 2 indexed citations

Zhang, Ke, Xiaomeng Yang, Haoran Sun, et al.. (2024). Modulating apoptosis as a novel therapeutic strategy against Respiratory Syncytial Virus infection: insights from Rotenone. Antiviral Research. 231. 106007–106007.

Huang, Yixin, Tong-Yun Wang, Yuxin Zhang, et al.. (2024). Molecular architecture of coronavirus double-membrane vesicle pore complex. Nature. 633(8028). 224–231. 32 indexed citations

Tang, Kaiming, Guilin Chen, Yubin Xie, et al.. (2024). An enhanced broad-spectrum peptide inhibits Omicron variants in vivo. Cell Reports Medicine. 5(2). 101418–101418. 5 indexed citations

Au, Man Ting, Kaiming Tang, Wei Wang, et al.. (2024). Blockade of endothelin receptors mitigates SARS-CoV-2-induced osteoarthritis. Nature Microbiology. 9(10). 2538–2552. 2 indexed citations

Yuan, Shuofeng, Fan Xiao, Hongyan Li, et al.. (2023). Metal-coding assisted serological multi-omics profiling deciphers the role of selenium in COVID-19 immunity. Chemical Science. 14(38). 10570–10579. 9 indexed citations

10.

Cai, Jian‐Piao, Cuiting Luo, Kun Wang, et al.. (2023). Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice. Viruses. 15(3). 687–687. 3 indexed citations

11.

Du, Qiaohui, Ronghui Liang, Meiling Wu, et al.. (2023). Alisol B 23-acetate broadly inhibits coronavirus through blocking virus entry and suppresses proinflammatory T cells responses for the treatment of COVID-19. Journal of Advanced Research. 62. 273–290. 4 indexed citations

12.

Qin, Bo, Ziheng Li, Kaiming Tang, et al.. (2023). Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target. Nature Communications. 14(1). 3999–3999. 16 indexed citations

13.

Xie, Yanan, Hong Yang, Anqi Lin, et al.. (2023). HPVTIMER: A shiny web application for tumor immune estimation in human papillomavirus‐associated cancers. SHILAP Revista de lepidopterología. 2(3). e130–e130. 31 indexed citations

14.

Qiao, Wei, Vincent Kwok‐Man Poon, Chris Chung‐Sing Chan, et al.. (2022). SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters. Nature Communications. 13(1). 44 indexed citations

15.

Wang, Juan, Yi‐Ling Chen, Jasper Fuk‐Woo Chan, et al.. (2021). A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities. European Journal of Medicinal Chemistry. 215. 113267–113267. 21 indexed citations

16.

Ye, Zi‐Wei, Shuofeng Yuan, Kit‐San Yuen, et al.. (2020). Zoonotic origins of human coronaviruses. International Journal of Biological Sciences. 16(10). 1686–1697. 600 indexed citations breakdown →

17.

Wong, Lok-Yin Roy, Zi‐Wei Ye, Pak‐Yin Lui, et al.. (2020). Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein Suppresses Type I IFN Expression by Impeding HSP70-Dependent Activation of IRF3 Kinase IKKε. The Journal of Immunology. 205(6). 1564–1579. 29 indexed citations

18.

Zhang, Jinxia, Andrew Chak-Yiu Lee, Hin Chu, et al.. (2020). SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters.. Clinical Infectious Diseases. 18 indexed citations

19.

Zhu, Zheng, Hin Chu, Lei Wen, et al.. (2019). Targeting SUMO Modification of the Non-Structural Protein 5 of Zika Virus as a Host-Targeting Antiviral Strategy. International Journal of Molecular Sciences. 20(2). 392–392. 23 indexed citations

20.

Zhao, Hanjun, Kelvin Kai‐Wang To, Hin Chu, et al.. (2018). Dual-functional peptide with defective interfering genes effectively protects mice against avian and seasonal influenza. Nature Communications. 9(1). 2358–2358. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact